Eastman Chemical Co

Eastman Chemical Co(EMN)股票分析

$62.880

-0.119 (-0.19%)收盤時

Loading chart…
最高
63.410
開盤
62.650
成交量加權均價
62.84
成交量
1.14M
市值
11.43B
最低
62.240
成交金額
71.50M
企業價值/稅息折舊攤銷前利潤(TTM)
6.75

Eastman Chemical Company is a global specialty materials company that produces a range of products found in items people use every day. Its segments include Advanced Materials (AM), Additives & Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma, and consumables end-markets. AFP segment manufactures materials for products in food, feed, and agriculture; transportation; water treatment and energy; personal care and wellness; building and construction; consumables, and durables and electronics end-markets. The CI segment sells intermediates for end-markets, such as industrial chemicals and processing, building and construction, health and wellness, and food and feed. Its Fibers segment manufactures and sells acetate tow and triacetin plasticizers.

AI 分析 of Eastman Chemical Co (EMN)

持有

Eastman Chemical Co is currently not a strong buy. The stock is priced at $62.69, with a low RSI of 26.39 indicating oversold conditions, but the forward P/E ratio of 9.20 suggests it may be undervalued. However, recent analyst downgrades have lowered price targets significantly, with UBS reducing its target from $92 to $77, indicating concerns about future performance. The main risk is the company's declining gross margin, which has fallen to 22.20% in Q2 2026 from 24.68% in Q4 2024, reflecting pressure on profitability.

分析師評級(18)

上檔空間 +18.32%
買進
11 買進
7 持有
0 賣出
目前: 62.88
最低
70.00
平均
74.40
最高
80.00

Barclays

2026-10-12

目標價

$72

持有

UBS

2026-10-05

目標價

$77

買進

Mizuho

2026-10-01

目標價

$80

優於大盤

Citi

2026-09-30

目標價

$76

買進

KeyBanc

2026-09-11

目標價

—

Sector Weight

估值指標

Eastman Chemical Co(EMN)目前預期本益比為 9.20,5 年平均預期本益比為 11.39。

預期本益比

低估
5 年均值 P/E
11.39
目前P/E
9.20
高估
12.75
低估
10.03

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
8.67
目前EV/EBITDA
6.75
高估
9.53
低估
7.81

預期股價營收比

低估
5 年均值 P/S
1.07
目前P/S
0.76
高估
1.27
低估
0.88

Alphio AI 對 EMN 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%EMN

$78.20

情境價格

基

基準

基準 · 50%EMN

$70.63

情境價格

悲

悲觀

悲觀 · 25%EMN

$64.35

情境價格

持有 EMN 的大戶

R

Recurrent Investment Advisors LLC

+ 持有EMN

+3.18%

3個月報酬率

L

Letko, Brosseau & Associates Inc.

+ 持有EMN

+2.00%

3個月報酬率

M

Miller Howard Investments, Inc.

+ 持有EMN

-0.43%

3個月報酬率

P

Polaris Capital Management, LLC

+ 持有EMN

-2.67%

3個月報酬率

EMN 常見問題 —— 由 Alphio AI 解答

Eastman Chemical Company is a global specialty materials company that produces a range of products found in items people use every day. Its segments include Advanced Materials (AM), Additives & Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma, and consumables end-markets. AFP segment manufactures materials for products in food, feed, and agriculture; transportation; water treatment and energy; personal care and wellness; building and construction; consumables, and durables and electronics end-markets. The CI segment sells intermediates for end-markets, such as industrial chemicals and processing, building and construction, health and wellness, and food and feed. Its Fibers segment manufactures and sells acetate tow and triacetin plasticizers. It operates in the Basic Materials sector (PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTO industry).

Eastman Chemical Co is currently not a strong buy. The stock is priced at $62.69, with a low RSI of 26.39 indicating oversold conditions, but the forward P/E ratio of 9.20 suggests it may be undervalued. However, recent analyst downgrades have lowered price targets significantly, with UBS reducing its target from $92 to $77, indicating concerns about future performance. The main risk is the company's declining gross margin, which has fallen to 22.20% in Q2 2026 from 24.68% in Q4 2024, reflecting pressure on profitability.

18 analysts cover EMN: 11 rate it Buy, 7 Hold and 0 Sell. The average price target is 74.40.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易